Nursing care
Hepatitis B Vaccination and Exposure, explained for the bedside and the exam
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Hepatitis B vaccination is a three-dose series given at 0, 1, and 6 months, and it is the standard occupational protection for healthcare workers. After a needlestick from a hepatitis B-positive source, an unvaccinated worker receives hepatitis B immune globulin within 24 hours plus the first vaccine dose, started as soon as possible.
Defining it precisely
The hepatitis B vaccine is a recombinant subunit vaccine given in a three-dose series, standard timing at 0, 1, and 6 months, that stimulates active immunity by prompting the body to produce its own anti-HBs antibodies. This is distinct from post-exposure prophylaxis, which uses hepatitis B immune globulin (HBIG) to deliver passive, ready-made antibodies immediately after a known exposure.
Occupational exposure typically means a needlestick, sharps injury, or mucous membrane splash involving blood or body fluid from a source patient. Management depends on two facts: the source patient's hepatitis B status, and the exposed worker's own vaccination and antibody status. Three doses, and after a needlestick from a positive source the unvaccinated worker gets immune globulin within 24 hours plus the first vaccine dose — that combination of passive and active protection is the core fact to hold onto.
The exceptions that matter
A worker who is already fully vaccinated with a documented adequate anti-HBs titre generally needs no treatment after exposure, since existing immunity covers the risk. This is the exception that trips people up: not every needlestick triggers HBIG, only ones involving inadequately protected workers.
If the source patient's hepatitis B status is unknown and cannot be tested quickly, the exposed worker is usually managed as though the source could be positive until proven otherwise, with the decision guided by institutional protocol and infectious disease consultation. A worker who has been vaccinated but never had titres checked, or whose prior response is unknown, is treated as a separate category requiring individualised assessment rather than assumed immunity.
Using it to prioritise
When a needlestick is reported, the immediate priority is wound care: wash the area with soap and water, do not scrub or apply caustic agents, and report the exposure through occupational health without delay. Time matters because HBIG effectiveness is highest when given promptly.
Next, establish the source patient's hepatitis B status and the worker's vaccination and titre history in parallel, since both determine the treatment path. If the worker is unvaccinated or has an inadequate response and the source is positive or unknown-high-risk, HBIG and vaccine dose one become time-sensitive actions, not routine follow-up items to schedule for later in the shift.
Traps in exam wording
Exam questions often test whether you know HBIG is passive immunity and the vaccine is active immunity, and whether you can identify which one, or both, a given scenario requires. A question describing a fully vaccinated worker with documented immunity is testing whether you avoid over-treating.
Watch for wording that specifies the source patient's status precisely: hepatitis B surface antigen positive, negative, or unknown each changes the answer. A question that says the worker was vaccinated but does not state titre results is deliberately incomplete, and the safest answer usually involves checking titres or treating as unprotected rather than assuming coverage.
Examples from practice
A new graduate nurse sustains a needlestick from a patient later confirmed hepatitis B surface antigen positive. The nurse has no vaccination record on file. Occupational health gives HBIG within 24 hours and starts the vaccine series with dose one, then schedules doses two and six months later.
A veteran nurse with documented anti-HBs immunity from a completed series years earlier is stuck by a needle from the same positive patient. Because the titre is documented as adequate, no HBIG or revaccination is required, and the exposure is logged with routine follow-up only. The difference between these two outcomes rests entirely on documented immune status, not on how the injury occurred.
Summary
Hepatitis B vaccination is a three-dose active immunisation series at 0, 1, and 6 months. Post-exposure management for an unvaccinated or inadequately immune worker after a positive-source needlestick means HBIG within 24 hours plus vaccine dose one, started without delay.
A fully vaccinated worker with documented adequate titres generally needs no post-exposure treatment. The exam and the ward both reward the same discipline: confirm the source's status, confirm the worker's immune status, and let those two facts, not the mechanism of injury, decide the response.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our gastrointestinal practice questions are the closest set to what this page covers.
Common questions
How many doses are in the hepatitis B vaccine series?
Three doses, typically given at 0, 1, and 6 months. This schedule is standard for healthcare workers and is usually completed before or early in employment.
What happens after a needlestick from a hepatitis B-positive patient?
An unvaccinated or inadequately immune worker receives hepatitis B immune globulin within 24 hours along with the first dose of the vaccine series, started as soon as possible. A fully immunised worker with documented adequate antibody levels generally needs no treatment.
Is hepatitis B immune globulin the same as the vaccine?
No. HBIG provides immediate passive immunity through ready-made antibodies, while the vaccine builds active, longer-lasting immunity by prompting the body to produce its own. After a high-risk exposure in an unprotected worker, both are typically given together.
Does every needlestick injury require hepatitis B treatment?
No. Treatment depends on the source patient's hepatitis B status and the exposed worker's vaccination and antibody status. A worker with documented immunity from a completed vaccine series usually requires no additional treatment.